Industry Research Reports

Home > Reports > Service & Software > Biopharmaceutical Testing Services - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Biopharmaceutical Testing Services - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Service & Software

Published Date: 2024-01-06

Pages: 131 Pages

Report ld: 2594482

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Biopharmaceutical testing is a critical step in the development of a biosimilar. Analytical testing provides the information needed to produce a safe and effective biopharmaceutical product, and the efficacy or safety depends on a product’s critical quality attributes (CQA). Biopharmaceutical testing involves the development, validation, and execution of wide-ranging cGMP analytical strategies, from routine tests to the application of state-of-the-art instrumental analysis, such as mass spectrometry.

The global market for Biopharmaceutical Testing Services was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

MARKET SEGMENTATION

By Company

Eurofins Scientific
SGS
Envigo
Exova Group
PPD Inc.
Pace Analytical Services
Intertek Group
DYNALABS
RD Laboratories
West Pharmaceutical Services
Polymer Solutions
Boston Analytical
Accuratus Labs
Microbac
ARLBioPharma
Lapuck Laboratories
BioScreen

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Raw Materials Testing
In-Process and Product Release Testing
Finished Pharmaceutical Products Testing
Environmental Samples
Others

Segment by Application

Hospitals
Clinics
Others

biaoTi REPORT SCOPE

This report aims to provide a comprehensive presentation of the global market for Biopharmaceutical Testing Services, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Biopharmaceutical Testing Services by region & country, by Type, and by Application.

The Biopharmaceutical Testing Services market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biopharmaceutical Testing Services.

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Biopharmaceutical Testing Services manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of Biopharmaceutical Testing Services in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of Biopharmaceutical Testing Services in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Biopharmaceutical Testing Services Product Introduction

1.2 Global Biopharmaceutical Testing Services Market Size Forecast

1.3 Biopharmaceutical Testing Services Market Trends & Drivers

1.3.1 Biopharmaceutical Testing Services Industry Trends

1.3.2 Biopharmaceutical Testing Services Market Drivers & Opportunity

1.3.3 Biopharmaceutical Testing Services Market Challenges

1.3.4 Biopharmaceutical Testing Services Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Biopharmaceutical Testing Services Players Revenue Ranking (2023)

2.2 Global Biopharmaceutical Testing Services Revenue by Company (2019-2024)

2.3 Key Companies Biopharmaceutical Testing Services Manufacturing Base Distribution and Headquarters

2.4 Key Companies Biopharmaceutical Testing Services Product Offered

2.5 Key Companies Time to Begin Mass Production of Biopharmaceutical Testing Services

2.6 Biopharmaceutical Testing Services Market Competitive Analysis

2.6.1 Biopharmaceutical Testing Services Market Concentration Rate (2019-2024)

2.6.2 Global 5 and 10 Largest Companies by Biopharmaceutical Testing Services Revenue in 2023

2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceutical Testing Services as of 2023)

2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Raw Materials Testing

3.1.2 In-Process and Product Release Testing

3.1.3 Finished Pharmaceutical Products Testing

3.1.4 Environmental Samples

3.1.5 Others

3.2 Global Biopharmaceutical Testing Services Sales Value by Type

3.2.1 Global Biopharmaceutical Testing Services Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Biopharmaceutical Testing Services Sales Value, by Type (2019-2030)

3.2.3 Global Biopharmaceutical Testing Services Sales Value, by Type (%) (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Hospitals

4.1.2 Clinics

4.1.3 Others

4.2 Global Biopharmaceutical Testing Services Sales Value by Application

4.2.1 Global Biopharmaceutical Testing Services Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Biopharmaceutical Testing Services Sales Value, by Application (2019-2030)

4.2.3 Global Biopharmaceutical Testing Services Sales Value, by Application (%) (2019-2030)

5 Segmentation by Region

5.1 Global Biopharmaceutical Testing Services Sales Value by Region

5.1.1 Global Biopharmaceutical Testing Services Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Biopharmaceutical Testing Services Sales Value by Region (2019-2024)

5.1.3 Global Biopharmaceutical Testing Services Sales Value by Region (2025-2030)

5.1.4 Global Biopharmaceutical Testing Services Sales Value by Region (%), (2019-2030)

5.2 North America

5.2.1 North America Biopharmaceutical Testing Services Sales Value, 2019-2030

5.2.2 North America Biopharmaceutical Testing Services Sales Value by Country (%), 2023 VS 2030

5.3 Europe

5.3.1 Europe Biopharmaceutical Testing Services Sales Value, 2019-2030

5.3.2 Europe Biopharmaceutical Testing Services Sales Value by Country (%), 2023 VS 2030

5.4 Asia Pacific

5.4.1 Asia Pacific Biopharmaceutical Testing Services Sales Value, 2019-2030

5.4.2 Asia Pacific Biopharmaceutical Testing Services Sales Value by Country (%), 2023 VS 2030

5.5 South America

5.5.1 South America Biopharmaceutical Testing Services Sales Value, 2019-2030

5.5.2 South America Biopharmaceutical Testing Services Sales Value by Country (%), 2023 VS 2030

5.6 Middle East & Africa

5.6.1 Middle East & Africa Biopharmaceutical Testing Services Sales Value, 2019-2030

5.6.2 Middle East & Africa Biopharmaceutical Testing Services Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Biopharmaceutical Testing Services Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Biopharmaceutical Testing Services Sales Value

6.3 United States

6.3.1 United States Biopharmaceutical Testing Services Sales Value, 2019-2030

6.3.2 United States Biopharmaceutical Testing Services Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Biopharmaceutical Testing Services Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Biopharmaceutical Testing Services Sales Value, 2019-2030

6.4.2 Europe Biopharmaceutical Testing Services Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Biopharmaceutical Testing Services Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Biopharmaceutical Testing Services Sales Value, 2019-2030

6.5.2 China Biopharmaceutical Testing Services Sales Value by Type (%), 2023 VS 2030

6.5.3 China Biopharmaceutical Testing Services Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Biopharmaceutical Testing Services Sales Value, 2019-2030

6.6.2 Japan Biopharmaceutical Testing Services Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Biopharmaceutical Testing Services Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Biopharmaceutical Testing Services Sales Value, 2019-2030

6.7.2 South Korea Biopharmaceutical Testing Services Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Biopharmaceutical Testing Services Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Biopharmaceutical Testing Services Sales Value, 2019-2030

6.8.2 Southeast Asia Biopharmaceutical Testing Services Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Biopharmaceutical Testing Services Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Biopharmaceutical Testing Services Sales Value, 2019-2030

6.9.2 India Biopharmaceutical Testing Services Sales Value by Type (%), 2023 VS 2030

6.9.3 India Biopharmaceutical Testing Services Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Eurofins Scientific

7.1.1 Eurofins Scientific Profile

7.1.2 Eurofins Scientific Main Business

7.1.3 Eurofins Scientific Biopharmaceutical Testing Services Products, Services and Solutions

7.1.4 Eurofins Scientific Biopharmaceutical Testing Services Revenue (US$ Million) & (2019-2024)

7.1.5 Eurofins Scientific Recent Developments

7.2 SGS

7.2.1 SGS Profile

7.2.2 SGS Main Business

7.2.3 SGS Biopharmaceutical Testing Services Products, Services and Solutions

7.2.4 SGS Biopharmaceutical Testing Services Revenue (US$ Million) & (2019-2024)

7.2.5 SGS Recent Developments

7.3 Envigo

7.3.1 Envigo Profile

7.3.2 Envigo Main Business

7.3.3 Envigo Biopharmaceutical Testing Services Products, Services and Solutions

7.3.4 Envigo Biopharmaceutical Testing Services Revenue (US$ Million) & (2019-2024)

7.3.5 Exova Group Recent Developments

7.4 Exova Group

7.4.1 Exova Group Profile

7.4.2 Exova Group Main Business

7.4.3 Exova Group Biopharmaceutical Testing Services Products, Services and Solutions

7.4.4 Exova Group Biopharmaceutical Testing Services Revenue (US$ Million) & (2019-2024)

7.4.5 Exova Group Recent Developments

7.5 PPD Inc.

7.5.1 PPD Inc. Profile

7.5.2 PPD Inc. Main Business

7.5.3 PPD Inc. Biopharmaceutical Testing Services Products, Services and Solutions

7.5.4 PPD Inc. Biopharmaceutical Testing Services Revenue (US$ Million) & (2019-2024)

7.5.5 PPD Inc. Recent Developments

7.6 Pace Analytical Services

7.6.1 Pace Analytical Services Profile

7.6.2 Pace Analytical Services Main Business

7.6.3 Pace Analytical Services Biopharmaceutical Testing Services Products, Services and Solutions

7.6.4 Pace Analytical Services Biopharmaceutical Testing Services Revenue (US$ Million) & (2019-2024)

7.6.5 Pace Analytical Services Recent Developments

7.7 Intertek Group

7.7.1 Intertek Group Profile

7.7.2 Intertek Group Main Business

7.7.3 Intertek Group Biopharmaceutical Testing Services Products, Services and Solutions

7.7.4 Intertek Group Biopharmaceutical Testing Services Revenue (US$ Million) & (2019-2024)

7.7.5 Intertek Group Recent Developments

7.8 DYNALABS

7.8.1 DYNALABS Profile

7.8.2 DYNALABS Main Business

7.8.3 DYNALABS Biopharmaceutical Testing Services Products, Services and Solutions

7.8.4 DYNALABS Biopharmaceutical Testing Services Revenue (US$ Million) & (2019-2024)

7.8.5 DYNALABS Recent Developments

7.9 RD Laboratories

7.9.1 RD Laboratories Profile

7.9.2 RD Laboratories Main Business

7.9.3 RD Laboratories Biopharmaceutical Testing Services Products, Services and Solutions

7.9.4 RD Laboratories Biopharmaceutical Testing Services Revenue (US$ Million) & (2019-2024)

7.9.5 RD Laboratories Recent Developments

7.10 West Pharmaceutical Services

7.10.1 West Pharmaceutical Services Profile

7.10.2 West Pharmaceutical Services Main Business

7.10.3 West Pharmaceutical Services Biopharmaceutical Testing Services Products, Services and Solutions

7.10.4 West Pharmaceutical Services Biopharmaceutical Testing Services Revenue (US$ Million) & (2019-2024)

7.10.5 West Pharmaceutical Services Recent Developments

7.11 Polymer Solutions

7.11.1 Polymer Solutions Profile

7.11.2 Polymer Solutions Main Business

7.11.3 Polymer Solutions Biopharmaceutical Testing Services Products, Services and Solutions

7.11.4 Polymer Solutions Biopharmaceutical Testing Services Revenue (US$ Million) & (2019-2024)

7.11.5 Polymer Solutions Recent Developments

7.12 Boston Analytical

7.12.1 Boston Analytical Profile

7.12.2 Boston Analytical Main Business

7.12.3 Boston Analytical Biopharmaceutical Testing Services Products, Services and Solutions

7.12.4 Boston Analytical Biopharmaceutical Testing Services Revenue (US$ Million) & (2019-2024)

7.12.5 Boston Analytical Recent Developments

7.13 Accuratus Labs

7.13.1 Accuratus Labs Profile

7.13.2 Accuratus Labs Main Business

7.13.3 Accuratus Labs Biopharmaceutical Testing Services Products, Services and Solutions

7.13.4 Accuratus Labs Biopharmaceutical Testing Services Revenue (US$ Million) & (2019-2024)

7.13.5 Accuratus Labs Recent Developments

7.14 Microbac

7.14.1 Microbac Profile

7.14.2 Microbac Main Business

7.14.3 Microbac Biopharmaceutical Testing Services Products, Services and Solutions

7.14.4 Microbac Biopharmaceutical Testing Services Revenue (US$ Million) & (2019-2024)

7.14.5 Microbac Recent Developments

7.15 ARLBioPharma

7.15.1 ARLBioPharma Profile

7.15.2 ARLBioPharma Main Business

7.15.3 ARLBioPharma Biopharmaceutical Testing Services Products, Services and Solutions

7.15.4 ARLBioPharma Biopharmaceutical Testing Services Revenue (US$ Million) & (2019-2024)

7.15.5 ARLBioPharma Recent Developments

7.16 Lapuck Laboratories

7.16.1 Lapuck Laboratories Profile

7.16.2 Lapuck Laboratories Main Business

7.16.3 Lapuck Laboratories Biopharmaceutical Testing Services Products, Services and Solutions

7.16.4 Lapuck Laboratories Biopharmaceutical Testing Services Revenue (US$ Million) & (2019-2024)

7.16.5 Lapuck Laboratories Recent Developments

7.17 BioScreen

7.17.1 BioScreen Profile

7.17.2 BioScreen Main Business

7.17.3 BioScreen Biopharmaceutical Testing Services Products, Services and Solutions

7.17.4 BioScreen Biopharmaceutical Testing Services Revenue (US$ Million) & (2019-2024)

7.17.5 BioScreen Recent Developments

8 Industry Chain Analysis

8.1 Biopharmaceutical Testing Services Industrial Chain

8.2 Biopharmaceutical Testing Services Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Biopharmaceutical Testing Services Sales Model

8.5.2 Sales Channel

8.5.3 Biopharmaceutical Testing Services Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Biopharmaceutical Testing Services Market Trends

Table 2. Biopharmaceutical Testing Services Market Drivers & Opportunity

Table 3. Biopharmaceutical Testing Services Market Challenges

Table 4. Biopharmaceutical Testing Services Market Restraints

Table 5. Global Biopharmaceutical Testing Services Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Biopharmaceutical Testing Services Revenue Market Share by Company (2019-2024)

Table 7. Key Companies Biopharmaceutical Testing Services Manufacturing Base Distribution and Headquarters

Table 8. Key Companies Biopharmaceutical Testing Services Product Type

Table 9. Key Companies Time to Begin Mass Production of Biopharmaceutical Testing Services

Table 10. Global Biopharmaceutical Testing Services Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceutical Testing Services as of 2023)

Table 12. Mergers & Acquisitions, Expansion Plans

Table 13. Global Biopharmaceutical Testing Services Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 14. Global Biopharmaceutical Testing Services Sales Value by Type (2019-2024) & (US$ Million)

Table 15. Global Biopharmaceutical Testing Services Sales Value by Type (2025-2030) & (US$ Million)

Table 16. Global Biopharmaceutical Testing Services Sales Market Share in Value by Type (2019-2024) & (%)

Table 17. Global Biopharmaceutical Testing Services Sales Market Share in Value by Type (2025-2030) & (%)

Table 18. Global Biopharmaceutical Testing Services Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 19. Global Biopharmaceutical Testing Services Sales Value by Application (2019-2024) & (US$ Million)

Table 20. Global Biopharmaceutical Testing Services Sales Value by Application (2025-2030) & (US$ Million)

Table 21. Global Biopharmaceutical Testing Services Sales Market Share in Value by Application (2019-2024) & (%)

Table 22. Global Biopharmaceutical Testing Services Sales Market Share in Value by Application (2025-2030) & (%)

Table 23. Global Biopharmaceutical Testing Services Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 24. Global Biopharmaceutical Testing Services Sales Value by Region (2019-2024) & (US$ Million)

Table 25. Global Biopharmaceutical Testing Services Sales Value by Region (2025-2030) & (US$ Million)

Table 26. Global Biopharmaceutical Testing Services Sales Value by Region (2019-2024) & (%)

Table 27. Global Biopharmaceutical Testing Services Sales Value by Region (2025-2030) & (%)

Table 28. Key Countries/Regions Biopharmaceutical Testing Services Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 29. Key Countries/Regions Biopharmaceutical Testing Services Sales Value, (2019-2024) & (US$ Million)

Table 30. Key Countries/Regions Biopharmaceutical Testing Services Sales Value, (2025-2030) & (US$ Million)

Table 31. Eurofins Scientific Basic Information List

Table 32. Eurofins Scientific Description and Business Overview

Table 33. Eurofins Scientific Biopharmaceutical Testing Services Products, Services and Solutions

Table 34. Revenue (US$ Million) in Biopharmaceutical Testing Services Business of Eurofins Scientific (2019-2024)

Table 35. Eurofins Scientific Recent Developments

Table 36. SGS Basic Information List

Table 37. SGS Description and Business Overview

Table 38. SGS Biopharmaceutical Testing Services Products, Services and Solutions

Table 39. Revenue (US$ Million) in Biopharmaceutical Testing Services Business of SGS (2019-2024)

Table 40. SGS Recent Developments

Table 41. Envigo Basic Information List

Table 42. Envigo Description and Business Overview

Table 43. Envigo Biopharmaceutical Testing Services Products, Services and Solutions

Table 44. Revenue (US$ Million) in Biopharmaceutical Testing Services Business of Envigo (2019-2024)

Table 45. Envigo Recent Developments

Table 46. Exova Group Basic Information List

Table 47. Exova Group Description and Business Overview

Table 48. Exova Group Biopharmaceutical Testing Services Products, Services and Solutions

Table 49. Revenue (US$ Million) in Biopharmaceutical Testing Services Business of Exova Group (2019-2024)

Table 50. Exova Group Recent Developments

Table 51. PPD Inc. Basic Information List

Table 52. PPD Inc. Description and Business Overview

Table 53. PPD Inc. Biopharmaceutical Testing Services Products, Services and Solutions

Table 54. Revenue (US$ Million) in Biopharmaceutical Testing Services Business of PPD Inc. (2019-2024)

Table 55. PPD Inc. Recent Developments

Table 56. Pace Analytical Services Basic Information List

Table 57. Pace Analytical Services Description and Business Overview

Table 58. Pace Analytical Services Biopharmaceutical Testing Services Products, Services and Solutions

Table 59. Revenue (US$ Million) in Biopharmaceutical Testing Services Business of Pace Analytical Services (2019-2024)

Table 60. Pace Analytical Services Recent Developments

Table 61. Intertek Group Basic Information List

Table 62. Intertek Group Description and Business Overview

Table 63. Intertek Group Biopharmaceutical Testing Services Products, Services and Solutions

Table 64. Revenue (US$ Million) in Biopharmaceutical Testing Services Business of Intertek Group (2019-2024)

Table 65. Intertek Group Recent Developments

Table 66. DYNALABS Basic Information List

Table 67. DYNALABS Description and Business Overview

Table 68. DYNALABS Biopharmaceutical Testing Services Products, Services and Solutions

Table 69. Revenue (US$ Million) in Biopharmaceutical Testing Services Business of DYNALABS (2019-2024)

Table 70. DYNALABS Recent Developments

Table 71. RD Laboratories Basic Information List

Table 72. RD Laboratories Description and Business Overview

Table 73. RD Laboratories Biopharmaceutical Testing Services Products, Services and Solutions

Table 74. Revenue (US$ Million) in Biopharmaceutical Testing Services Business of RD Laboratories (2019-2024)

Table 75. RD Laboratories Recent Developments

Table 76. West Pharmaceutical Services Basic Information List

Table 77. West Pharmaceutical Services Description and Business Overview

Table 78. West Pharmaceutical Services Biopharmaceutical Testing Services Products, Services and Solutions

Table 79. Revenue (US$ Million) in Biopharmaceutical Testing Services Business of West Pharmaceutical Services (2019-2024)

Table 80. West Pharmaceutical Services Recent Developments

Table 81. Polymer Solutions Basic Information List

Table 82. Polymer Solutions Description and Business Overview

Table 83. Polymer Solutions Biopharmaceutical Testing Services Products, Services and Solutions

Table 84. Revenue (US$ Million) in Biopharmaceutical Testing Services Business of Polymer Solutions (2019-2024)

Table 85. Polymer Solutions Recent Developments

Table 86. Boston Analytical Basic Information List

Table 87. Boston Analytical Description and Business Overview

Table 88. Boston Analytical Biopharmaceutical Testing Services Products, Services and Solutions

Table 89. Revenue (US$ Million) in Biopharmaceutical Testing Services Business of Boston Analytical (2019-2024)

Table 90. Boston Analytical Recent Developments

Table 91. Accuratus Labs Basic Information List

Table 92. Accuratus Labs Description and Business Overview

Table 93. Accuratus Labs Biopharmaceutical Testing Services Products, Services and Solutions

Table 94. Revenue (US$ Million) in Biopharmaceutical Testing Services Business of Accuratus Labs (2019-2024)

Table 95. Accuratus Labs Recent Developments

Table 96. Microbac Basic Information List

Table 97. Microbac Description and Business Overview

Table 98. Microbac Biopharmaceutical Testing Services Products, Services and Solutions

Table 99. Revenue (US$ Million) in Biopharmaceutical Testing Services Business of Microbac (2019-2024)

Table 100. Microbac Recent Developments

Table 101. ARLBioPharma Basic Information List

Table 102. ARLBioPharma Description and Business Overview

Table 103. ARLBioPharma Biopharmaceutical Testing Services Products, Services and Solutions

Table 104. Revenue (US$ Million) in Biopharmaceutical Testing Services Business of ARLBioPharma (2019-2024)

Table 105. ARLBioPharma Recent Developments

Table 106. Lapuck Laboratories Basic Information List

Table 107. Lapuck Laboratories Description and Business Overview

Table 108. Lapuck Laboratories Biopharmaceutical Testing Services Products, Services and Solutions

Table 109. Revenue (US$ Million) in Biopharmaceutical Testing Services Business of Lapuck Laboratories (2019-2024)

Table 110. Lapuck Laboratories Recent Developments

Table 111. BioScreen Basic Information List

Table 112. BioScreen Description and Business Overview

Table 113. BioScreen Biopharmaceutical Testing Services Products, Services and Solutions

Table 114. Revenue (US$ Million) in Biopharmaceutical Testing Services Business of BioScreen (2019-2024)

Table 115. BioScreen Recent Developments

Table 116. Key Raw Materials Lists

Table 117. Raw Materials Key Suppliers Lists

Table 118. Biopharmaceutical Testing Services Downstream Customers

Table 119. Biopharmaceutical Testing Services Distributors List

Table 120. Research Programs/Design for This Report

Table 121. Key Data Information from Secondary Sources

Table 122. Key Data Information from Primary Sources

Table 123. Business Unit and Senior & Team Lead Analysts

List of Figures

Figure 1. Biopharmaceutical Testing Services Product Picture

Figure 2. Global Biopharmaceutical Testing Services Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Biopharmaceutical Testing Services Sales Value (2019-2030) & (US$ Million)

Figure 4. Biopharmaceutical Testing Services Report Years Considered

Figure 5. Global Biopharmaceutical Testing Services Players Revenue Ranking (2023) & (US$ Million)

Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Biopharmaceutical Testing Services Revenue in 2023

Figure 7. Biopharmaceutical Testing Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 8. Raw Materials Testing Picture

Figure 9. In-Process and Product Release Testing Picture

Figure 10. Finished Pharmaceutical Products Testing Picture

Figure 11. Environmental Samples Picture

Figure 12. Others Picture

Figure 13. Global Biopharmaceutical Testing Services Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 14. Global Biopharmaceutical Testing Services Sales Value Market Share by Type, 2023 & 2030

Figure 15. Product Picture of Hospitals

Figure 16. Product Picture of Clinics

Figure 17. Product Picture of Others

Figure 18. Global Biopharmaceutical Testing Services Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 19. Global Biopharmaceutical Testing Services Sales Value Market Share by Application, 2023 & 2030

Figure 20. North America Biopharmaceutical Testing Services Sales Value (2019-2030) & (US$ Million)

Figure 21. North America Biopharmaceutical Testing Services Sales Value by Country (%), 2023 VS 2030

Figure 22. Europe Biopharmaceutical Testing Services Sales Value (2019-2030) & (US$ Million)

Figure 23. Europe Biopharmaceutical Testing Services Sales Value by Country (%), 2023 VS 2030

Figure 24. Asia Pacific Biopharmaceutical Testing Services Sales Value (2019-2030) & (US$ Million)

Figure 25. Asia Pacific Biopharmaceutical Testing Services Sales Value by Country (%), 2023 VS 2030

Figure 26. South America Biopharmaceutical Testing Services Sales Value (2019-2030) & (US$ Million)

Figure 27. South America Biopharmaceutical Testing Services Sales Value by Country (%), 2023 VS 2030

Figure 28. Middle East & Africa Biopharmaceutical Testing Services Sales Value (2019-2030) & (US$ Million)

Figure 29. Middle East & Africa Biopharmaceutical Testing Services Sales Value by Country (%), 2023 VS 2030

Figure 30. Key Countries/Regions Biopharmaceutical Testing Services Sales Value (%), (2019-2030)

Figure 31. United States Biopharmaceutical Testing Services Sales Value, (2019-2030) & (US$ Million)

Figure 32. United States Biopharmaceutical Testing Services Sales Value by Type (%), 2023 VS 2030

Figure 33. United States Biopharmaceutical Testing Services Sales Value by Application (%), 2023 VS 2030

Figure 34. Europe Biopharmaceutical Testing Services Sales Value, (2019-2030) & (US$ Million)

Figure 35. Europe Biopharmaceutical Testing Services Sales Value by Type (%), 2023 VS 2030

Figure 36. Europe Biopharmaceutical Testing Services Sales Value by Application (%), 2023 VS 2030

Figure 37. China Biopharmaceutical Testing Services Sales Value, (2019-2030) & (US$ Million)

Figure 38. China Biopharmaceutical Testing Services Sales Value by Type (%), 2023 VS 2030

Figure 39. China Biopharmaceutical Testing Services Sales Value by Application (%), 2023 VS 2030

Figure 40. Japan Biopharmaceutical Testing Services Sales Value, (2019-2030) & (US$ Million)

Figure 41. Japan Biopharmaceutical Testing Services Sales Value by Type (%), 2023 VS 2030

Figure 42. Japan Biopharmaceutical Testing Services Sales Value by Application (%), 2023 VS 2030

Figure 43. South Korea Biopharmaceutical Testing Services Sales Value, (2019-2030) & (US$ Million)

Figure 44. South Korea Biopharmaceutical Testing Services Sales Value by Type (%), 2023 VS 2030

Figure 45. South Korea Biopharmaceutical Testing Services Sales Value by Application (%), 2023 VS 2030

Figure 46. Southeast Asia Biopharmaceutical Testing Services Sales Value, (2019-2030) & (US$ Million)

Figure 47. Southeast Asia Biopharmaceutical Testing Services Sales Value by Type (%), 2023 VS 2030

Figure 48. Southeast Asia Biopharmaceutical Testing Services Sales Value by Application (%), 2023 VS 2030

Figure 49. India Biopharmaceutical Testing Services Sales Value, (2019-2030) & (US$ Million)

Figure 50. India Biopharmaceutical Testing Services Sales Value by Type (%), 2023 VS 2030

Figure 51. India Biopharmaceutical Testing Services Sales Value by Application (%), 2023 VS 2030

Figure 52. Biopharmaceutical Testing Services Industrial Chain

Figure 53. Biopharmaceutical Testing Services Manufacturing Cost Structure

Figure 54. Channels of Distribution (Direct Sales, and Distribution)

Figure 55. Bottom-up and Top-down Approaches for This Report

Figure 56. Data Triangulation

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Biopharmaceutical Testing Services market? zhanKai

The top companies in the global Biopharmaceutical Testing Services market are Eurofins Scientific、SGS、Envigo.

Related Reports

Biopharmaceutical Testing Services - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Biopharmaceutical Testing Services was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-14
Pages: 121
USD 3950.00
(Single User License)
Global Biopharmaceutical Testing Services Market Research Report 2026
The global Biopharmaceutical Testing Services market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-21
Pages: 134
USD 2900.00
(Single User License)
Global Biopharmaceutical Testing Services Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Biopharmaceutical Testing Services market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-10-23
Pages: 153
USD 4900.00
(Single User License)
Global Biopharmaceutical Testing Services Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Biopharmaceutical Testing Services market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-20
Pages: 101
USD 4250.00
(Single User License)
Biopharmaceutical Testing Services- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Biopharmaceutical Testing Services was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-20
Pages: 139
USD 3950.00
(Single User License)
Global Biopharmaceutical Testing Services Market Research Report 2025
The global market for Biopharmaceutical Testing Services was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-20
Pages: 95
USD 2900.00
(Single User License)
Global Biopharmaceutical Testing Services Market Insights, Forecast to 2030
Biopharmaceutical testing is a critical step in the development of a biosimilar. Analytical testing provides the information needed to produce a safe and effective biopharmaceutical product, and the efficacy or safety depends on a product’s critical quality attributes (CQA). Biopharmaceutical testing involves the development, validation, and execution of wide-ranging cGMP analytical strategies, from routine tests to the application of state-of-the-art instrumental analysis, such as mass spectrometry.
Published Date: 2024-04-19
Pages: 113
USD 4900.00
(Single User License)
Global Biopharmaceutical Testing Services Market Research Report 2024
Biopharmaceutical testing is a critical step in the development of a biosimilar. Analytical testing provides the information needed to produce a safe and effective biopharmaceutical product, and the efficacy or safety depends on a product’s critical quality attributes (CQA). Biopharmaceutical testing involves the development, validation, and execution of wide-ranging cGMP analytical strategies, from routine tests to the application of state-of-the-art instrumental analysis, such as mass spectrometry.
Published Date: 2024-01-17
Pages: 90
USD 2900.00
(Single User License)

Biopharmaceutical Testing Services - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Biopharmaceutical Testing Services was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-14
Pages: 121
USD 3950.00 (Single User License)
Global Biopharmaceutical Testing Services Market Research Report 2026
The global Biopharmaceutical Testing Services market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-21
Pages: 134
USD 2900.00 (Single User License)
Global Biopharmaceutical Testing Services Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Biopharmaceutical Testing Services market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-10-23
Pages: 153
USD 4900.00 (Single User License)
Global Biopharmaceutical Testing Services Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Biopharmaceutical Testing Services market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-20
Pages: 101
USD 4250.00 (Single User License)
Biopharmaceutical Testing Services- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Biopharmaceutical Testing Services was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-20
Pages: 139
USD 3950.00 (Single User License)
Global Biopharmaceutical Testing Services Market Research Report 2025
The global market for Biopharmaceutical Testing Services was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-20
Pages: 95
USD 2900.00 (Single User License)
Global Biopharmaceutical Testing Services Market Insights, Forecast to 2030
Biopharmaceutical testing is a critical step in the development of a biosimilar. Analytical testing provides the information needed to produce a safe and effective biopharmaceutical product, and the efficacy or safety depends on a product’s critical quality attributes (CQA). Biopharmaceutical testing involves the development, validation, and execution of wide-ranging cGMP analytical strategies, from routine tests to the application of state-of-the-art instrumental analysis, such as mass spectrometry.
Published: 2024-04-19
Pages: 113
USD 4900.00 (Single User License)
Global Biopharmaceutical Testing Services Market Research Report 2024
Biopharmaceutical testing is a critical step in the development of a biosimilar. Analytical testing provides the information needed to produce a safe and effective biopharmaceutical product, and the efficacy or safety depends on a product’s critical quality attributes (CQA). Biopharmaceutical testing involves the development, validation, and execution of wide-ranging cGMP analytical strategies, from routine tests to the application of state-of-the-art instrumental analysis, such as mass spectrometry.
Published: 2024-01-17
Pages: 90
USD 2900.00 (Single User License)